A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs
Clinical trial NCT01878318 · WITHDRAWN
Trial details
- NCT number
- NCT01878318
- Sponsor
- Hoffmann-La Roche
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2015-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.